Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017

• Main Authors: Christer F. Aas (Author), Jørn Henrik Vold (Author), Svetlana Skurtveit (Author), Ingvild Odsbu (Author), Fatemeh Chalabianloo (Author), Aaron G. Lim (Author), Kjell Arne Johansson (Author), Lars Thore Fadnes (Author)
• Format: Book
• Published: BMC, 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Treatment with direct-acting antiviral agents (DAAs) offers an opportunity to eliminate hepatitis C virus (HCV) endemic among people who inject drugs (PWID) and people enrolled in opioid agonist therapy (OAT) programs. The objective of this study was to estimate and to compare HC...